Found 13 matching trials
A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma PHASE1 This study will evaluate the safety, tolerability and pharmacokinetics of C...
Show More Location
Angeles Clinic and Research Institute
Learn More & Join Trial
Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery PHASE1 This phase Ib/II trial studies the best dose of glembatumumab vedotin when ...
Show More Location
Multiple Locations
Learn More & Join Trial
Individual Patient Expanded Access-Glembatumumab Vedotin N/A Celldex endeavors to make investigational products available to patients wi...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer PHASE2 The main purpose of this study is to see whether CDX-011 (glembatumumab ved...
Show More Learn More & Join Trial
Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma PHASE2 This phase II trial studies how well glembatumumab vedotin works in treatin...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
CAR T Therapy With GCAR1 for Relapsed Alveolar Soft Part Sarcoma EARLY_PHASE1 A single patient study to determine whether GCAR1 is safe and effective for...
Show More Status
Active Not Recruiting
Location
Arthur J.E. Child Comprehensive Cancer Centre
Learn More & Join Trial
Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma PHASE2 This phase II trial studies how well glembatumumab vedotin works in treatin...
Show More Location
Mayo Clinic Hospital
Learn More & Join Trial
Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer PHASE1 This study will evaluate the safety and tolerability of CR011-vcMMAE in pat...
Show More Location
Florida Cancer Specialists
Learn More & Join Trial
Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung PHASE1 Patients with advanced or metastatic, gpNMB-expressing Squamous Cell Carcin...
Show More Location
University of Miami Hospital
Learn More & Join Trial
Pilot Study of Glembatumumab Vedotin Following Doxorubicin and Cytoxan as Neo-adjuvant Therapy in Gp-NMB-expressing High Risk Triple Negative Breast Cancer EARLY_PHASE1 This is a single arm, pilot study assessing safety/feasibility and efficacy...
Show More Location
Multiple Locations
Learn More & Join Trial